Viral proteases

L Tong - Chemical Reviews, 2002 - ACS Publications
Viruses are major pathogenic agents that can cause a variety of serious diseases in
humans, other animals, and plants. Due to their clinical and scientific importance, viruses …

Recent advances in the molecular biology of hepatitis C virus

S Rosenberg - Journal of molecular biology, 2001 - Elsevier
The Hepatitis C virus is a positive-stranded RNA virus which is the causal agent for a chronic
liver infection afflicting more than 170,000,000 people world-wide. The HCV genome is …

Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection

YS Tsantrizos, G Bolger, P Bonneau… - Angewandte …, 2003 - Wiley Online Library
The hepatitis C virus (HCV) is the etiologic agent of chronic hepatitis C infection, an
important health problem that can lead to cirrhosis of the liver and hepatocellular carcinoma …

A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors

M Llinas-Brunet, MD Bailey, E Ghiro… - Journal of Medicinal …, 2004 - ACS Publications
The inadequate efficacy and tolerability of current therapies for the infectious liver disease
caused by the hepatitis C virus have warranted significant efforts in the development of new …

Control of hepatitis C: a medicinal chemistry perspective

CP Gordon, PA Keller - Journal of Medicinal Chemistry, 2005 - ACS Publications
Hepatitis C virus (HCV) is a common pathogen with an estimated 170 million people
infected worldwide in the year 2000. 1 The virus was unambiguously identified in 1989 as …

Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection

GV Gregorio, K Choudhuri, Y Ma… - Clinical & …, 2003 - academic.oup.com
Autoantibodies to smooth muscle (SMA) and nuclear components (ANA) arise in the natural
course of chronic infection with hepatitis C virus. In view of the growing evidence for …

Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation

P Niyomrattanakit, P Winoyanuwattikun… - Journal of …, 2004 - Am Soc Microbiol
Proteolytic processing of the dengue virus polyprotein is mediated by host cell proteases
and the virus-encoded NS2B-NS3 two-component protease. The NS3 protease represents …

[HTML][HTML] Piperazine-derived small molecules as potential Flaviviridae NS3 protease inhibitors. In vitro antiviral activity evaluation against Zika and Dengue viruses

M del Rosario García-Lozano, F Dragoni, P Gallego… - Bioorganic …, 2023 - Elsevier
Abstract Since 2011 Direct Acting antivirals (DAAs) drugs targeting different non-structural
(NS) viral proteins (NS3, NS5A or NS5B inhibitors) have been approved for clinical use in …

Solid-phase synthesis of peptidomimetic inhibitors for the hepatitis C virus NS3 protease

MA Poupart, DR Cameron, C Chabot… - The Journal of …, 2001 - ACS Publications
The NS3 serine protease enzyme of the hepatitis C virus (HCV) is essential for viral
replication. Short peptides mimicking the N-terminal substrate cleavage products of the NS3 …

Potent inhibitors of the hepatitis C virus NS3 protease: design and synthesis of macrocyclic substrate-based β-strand mimics

N Goudreau, C Brochu, DR Cameron… - The Journal of …, 2004 - ACS Publications
The virally encoded NS3 protease is essential to the life cycle of the hepatitis C virus (HCV),
an important human pathogen causing chronic hepatitis, cirrhosis of the liver, and …